Infectious Disease
Straight Talk on COVID-19 | September 2022
Straight talk on COVID-19 is a series by MDBriefCase featuring internationally recognized clinicians.
In this installment (filmed in September 2022), our experts discuss their opinions on the following Frequently Asked Questions:
- Discuss the potential role of the new bivalent COVID-19 booster to reduce the risk of infection from the omicron variant
- Examine the development of intranasal COVID-19 vaccines and how they differ from other COVID-19 options
- Determine the ideal strategies to ensure patients are protected from both COVID-19 and influenza during the upcoming flu season
- Educate patients on the impact and the current management strategies for long COVID
DURATION
35 min
PROFESSION
Physician, Nursing, Pharmacy, Allied Health, Medical Resident, Student, Specialist
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2023-09-20
Straight talk on COVID-19 is a series by MDBriefCase featuring internationally recognized clinicians.
In this installment (filmed in September 2022), our experts discuss their opinions on the following Frequently Asked Questions:
- Discuss the potential role of the new bivalent COVID-19 booster to reduce the risk of infection from the omicron variant
- Examine the development of intranasal COVID-19 vaccines and how they differ from other COVID-19 options
- Determine the ideal strategies to ensure patients are protected from both COVID-19 and influenza during the upcoming flu season
- Educate patients on the impact and the current management strategies for long COVID
This is a non-sponsored program with in-kind support from MDBriefCase.
Faculty
David Strain, MB, ChB, BSc (Hons) MD, FRCP
Clinical lead for the COVID service in the SW of England, and Clinical Senior lecturer at the University of Exeter.
Peter J. Lin, MD, CCFP
Director Primary Care Initiatives
Canadian Heart Research Centre
Michael Boivin, RPh, BScPhm
Clinical pharmacist consultant and continuing education developer